301333 fundamentals
An in-depth look to R&G PHARMASTUDIES operating, investing, and financing activities
301333 free cash flow for Q3 24 is 48.18 M CNY. For 2023, 301333 free cash flow was 197.74 M CNY and operating cash flow was 217.62 M CNY.
Q4 '19
Q3 '20
Q4 '20
Q2 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q4 '19
Q3 '20
Q4 '20
Q2 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM